Insider trading

Period: 120 months Stock: TMDX + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

230 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

230 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

230 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

230 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
230 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
230 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

230 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
10 Mar 2021
Hassanein Waleed H President & CEO
Sold, plan not stated 2×
$1.18M 35,007 at 33.79
9.4%
8 Mar 2021
Khayal Tamer I Chief Commercial Officer
Sold, plan not stated
$640.00K 20,000 at 32.00
30.3%
5 Mar 2021
Khayal Tamer I Chief Commercial Officer
Sold, plan not stated 2×
$618.10K 20,000 at 30.90
30.3%
16 Feb 2021
Gordon Stephen Chief Financial Officer
Sold, plan not stated
$313.30K 10,000 at 31.33
100%
Sold half or more
9 Feb 2021
ABRAMS CAPITAL MANAGEMENT, L.P. 10% owner · indirect
Sold, plan not stated
$26.21M 786,664 at 33.32
23.1%
9 Feb 2021
TOBIN JAMES R Director · indirect
Sold, plan not stated 2×
$333.79K 10,168 at 32.83
2.3%
9 Feb 2021
Sullivan John F VP of Quality & Engineering
Sold, plan not stated 2×
$282.19K 8,600 at 32.81
44.3%
8 Feb 2021
ABRAMS CAPITAL MANAGEMENT, L.P. 10% owner · indirect
Sold, plan not stated
$2.32M 88,483 at 26.24
2.5%
8 Feb 2021
Gordon Stephen Chief Financial Officer
Sold, plan not stated 2×
$250.10K 10,000 at 25.01
100%
Sold half or more
19 Jan 2021
Sullivan John F VP of Quality & Engineering
Sold, plan not stated
$212.73K 9,617 at 22.12
47.0%
4 Jan 2021
Gordon Stephen Chief Financial Officer
Sold, plan not stated
$23.68K 1,184 at 20.00
12.4%
31 Dec 2020
Gordon Stephen Chief Financial Officer
Sold, plan not stated
$176.32K 8,816 at 20.00
47.5%
21 Dec 2020
Sullivan John F VP of Quality & Engineering
Sold, plan not stated
$17.99K 1,000 at 17.99
8.5%
15 Dec 2020
Sullivan John F VP of Quality & Engineering
Sold, plan not stated
$49.89K 3,000 at 16.63
21.7%
1 Sep 2020
Carey John F VP of Operations
Sold, plan not stated
$35.18K 2,000 at 17.59
38.5%
3 Aug 2020
Carey John F VP of Operations
Sold, plan not stated 2×
$37.21K 2,000 at 18.61
38.5%
1 Jul 2020
Carey John F VP of Operations
Sold, plan not stated 2×
$34.17K 2,000 at 17.09
38.5%
1 Jun 2020
Carey John F VP of Operations
Sold, plan not stated
$26.42K 2,000 at 13.21
38.5%
1 May 2020
Carey John F VP of Operations
Sold, plan not stated 2×
$34.11K 2,000 at 17.05
38.5%
27 Apr 2020
Gordon Stephen Chief Financial Officer
Sold, plan not stated
$178.20K 9,900 at 18.00
34.8%
22 Apr 2020
Gordon Stephen Chief Financial Officer
Sold, plan not stated
$1.80K 100 at 18.00
0.4%
7 Apr 2020
Carey John F VP of Operations
Sold, plan not stated
$26.20K 2,000 at 13.10
38.5%
2 Mar 2020
Carey John F VP of Operations
Sold, plan not stated 2×
$30.35K 2,000 at 15.17
38.5%
3 Feb 2020
Carey John F VP of Operations
Sold, plan not stated
$35.42K 2,000 at 17.71
62.5%
Sold half or more
21 Jan 2020
Khayal Tamer I Chief Commercial Officer
Sold, plan not stated
$100.10K 5,000 at 20.02
9.8%
2 Jan 2020
Carey John F VP of Operations
Sold, plan not stated
$37.90K 2,000 at 18.95
62.5%
Sold half or more
9 Dec 2019
UNITED THERAPEUTICS Corp 10% owner · indirect
Sold, plan not stated
$9.38M 500,000 at 18.75
19.6%
11 Nov 2019
Weill David Director
Bought
$170.00K 10,000 at 17.00
opened
First buy on file
6 May 2019
Kania Edwin Director
Bought
$533.33K 33,333 at 16.00
opened
First buy on file
6 May 2019
Basile Edward M Director
Bought
$136.00K 8,500 at 16.00
59.4%
First buy on file
Showing 201–230 of 230. ← Newer Page 5 of 5